Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease

dc.contributor.authorHarlow, Kathryn E.
dc.contributor.authorAfrica, Jonathan A.
dc.contributor.authorWells, Alan
dc.contributor.authorBelt, Patricia H.
dc.contributor.authorBehling, Cynthia A.
dc.contributor.authorJain, Ajay K.
dc.contributor.authorMolleston, Jean P.
dc.contributor.authorNewton, Kimberly P.
dc.contributor.authorRosenthal, Philip
dc.contributor.authorVos, Miriam B.
dc.contributor.authorXanthakos, Stavra A.
dc.contributor.authorLavine, Joel E.
dc.contributor.authorSchwimmer, Jeffrey B.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2019-09-03T19:17:33Z
dc.date.available2019-09-03T19:17:33Z
dc.date.issued2018-07
dc.description.abstractOBJECTIVE: To determine the percentage of children with nonalcoholic fatty liver disease (NAFLD) in whom intervention for low-density lipoprotein cholesterol or triglycerides was indicated based on National Heart, Lung, and Blood Institute guidelines. STUDY DESIGN: This multicenter, longitudinal cohort study included children with NAFLD enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases Nonalcoholic Steatohepatitis Clinical Research Network. Fasting lipid profiles were obtained at diagnosis. Standardized dietary recommendations were provided. After 1 year, lipid profiles were repeated and interpreted according to National Heart, Lung, and Blood Institute Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction. Main outcomes were meeting criteria for clinically actionable dyslipidemia at baseline, and either achieving lipid goal at follow-up or meeting criteria for ongoing intervention. RESULTS: There were 585 participants, with a mean age of 12.8 years. The prevalence of children warranting intervention for low-density lipoprotein cholesterol at baseline was 14%. After 1 year of recommended dietary changes, 51% achieved goal low-density lipoprotein cholesterol, 27% qualified for enhanced dietary and lifestyle modifications, and 22% met criteria for pharmacologic intervention. Elevated triglycerides were more prevalent, with 51% meeting criteria for intervention. At 1 year, 25% achieved goal triglycerides with diet and lifestyle changes, 38% met criteria for advanced dietary modifications, and 37% qualified for antihyperlipidemic medications. CONCLUSIONS: More than one-half of children with NAFLD met intervention thresholds for dyslipidemia. Based on the burden of clinically relevant dyslipidemia, lipid screening in children with NAFLD is warranted. Clinicians caring for children with NAFLD should be familiar with lipid management.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationHarlow, K. E., Africa, J. A., Wells, A., Belt, P. H., Behling, C. A., Jain, A. K., … Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) (2018). Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. The Journal of pediatrics, 198, 76–83.e2. doi:10.1016/j.jpeds.2018.02.038en_US
dc.identifier.urihttps://hdl.handle.net/1805/20761
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.jpeds.2018.02.038en_US
dc.relation.journalThe Journal of Pediatricsen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectPediatricen_US
dc.subjectNAFLDen_US
dc.subjectDyslipidemiaen_US
dc.subjectCardiovascularen_US
dc.subjectDieten_US
dc.subjectStrainen_US
dc.titleClinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Diseaseen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms960123.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: